Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
7.14
+0.19 (2.73%)
At close: Jun 2, 2025, 4:00 PM
7.19
+0.05 (0.70%)
After-hours: Jun 2, 2025, 7:50 PM EDT
Exagen Employees
As of December 31, 2024, Exagen had 215 total employees, including 209 full-time and 6 part-time employees. The number of employees increased by 36 or 20.11% compared to the previous year.
Employees
215
Change (1Y)
36
Growth (1Y)
20.11%
Revenue / Employee
$263,833
Profits / Employee
-$72,126
Market Cap
156.04M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
XGN News
- 24 days ago - Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares - GlobeNewsWire
- 25 days ago - Exagen Inc. Prices Public Offering of Common Stock - GlobeNewsWire
- 26 days ago - Exagen Inc. Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 4 weeks ago - Exagen Inc. (XGN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing Volume - GlobeNewsWire
- 5 weeks ago - Exagen Inc. Announces Senior Secured Credit Facility with Perceptive Advisors - GlobeNewsWire
- 5 weeks ago - Exagen: Buy An Undervalued Diagnostics Developer That Is On The Path To Profitability - Seeking Alpha
- 6 weeks ago - Exagen Inc. to Announce First Quarter 2025 Financial Results on May 5, 2025 - GlobeNewsWire